WA Parliamentary Question on Notice regarding pharmacological treatments for gender dysphoria in minors between 2015 and 2024, detailing medications prescribed, prescription numbers, and age breakdowns. The answer provides a list of medications and the total number of distinct young people prescribed each medication.

AnsweredQoN 695Legislative Council
Asked
15 October 2025
Portfolio
Health

QuestionView source ↗

I refer to pharmacological treatments for gender dysphoria provided to minors in Western Australia, and I ask, for each calendar year between 2015 and 2024, please provide the following: (a) what medications, by active ingredient, were prescribed to persons under 18 years for puberty suppression or gender-related hormone therapy; (b) for each medication identified in (a), how many prescriptions to persons under 18 years were recorded; and (c) in reference to (b), what was the age breakdown of these patients (under 12; 12–15; 16–17)?

AnswerView source ↗

Answered
20 November 2025
Responded by
Parliamentary Secretary to the Minister for Health
Response time
10 days
(a)
Cyproterone Acetate, Leuprorelin Acetate, Oestradiol, Spironolactone, and Testosterone.
(b-c)
Active Ingredient
Total distinct young people
Cyproterone Acetate
12
Leuprorelin Acetate
137
Oestradiol
39
Spironolactone
32
Testosterone
100
*In the table above, a distinct young person may be counted more than once as they may change medication throughout their care journey.

Explore WA Government Data

Search the full archive in the free dashboard, or query programmatically via API.

Explore more